Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05555407 · ClinicalTrials.gov registry record · NA

Feasibility of a Wireless Patch System (WPS) to Measure Gastrointestinal Motility and Gastric Emptying

A NA study of Gastric Emptying, sponsored by Mayo Clinic.

Completed
Registry status
NA
Development phase
23
Enrollment target
1
Study location

NCT05555407: Completed NA study of Gastric Emptying, sponsored by Mayo Clinic.

NCT05555407 is a NA study of Gastric Emptying that has completed, run by Mayo Clinic. The registered enrollment target is 23 participants, below the 132-participant average among 5 other Gastric Emptying trials with a reported enrollment target (83% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05555407, a NA study of Gastric Emptying, has completed, sponsored by Mayo Clinic.

COMPLETED
Registry status
NA
Development phase
23 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to evaluate the utility of a new device - an external wireless patch system (WPS) - to measure gastric motility and to compare this external wearable device with the most commonly used test to measure stomach emptying, the nuclear medicine gastric emptying scan (also called gastric scintigraphy).

Primary Outcome

Number of subjects to wear a wireless patch system (WPS) to evaluate upper gastrointestinal symptoms

Conditions Studied

Interventions

  • DIAGNOSTIC_TEST Scintigraphic gastric emptying scan
  • DEVICE Wireless patch system (WPS)

Study Locations (1)

Florida

  • Mayo Clinic Florida - Jacksonville

Trial Details

FieldValue
Enrollment Target 23 participants
Start Date 2022-08-01
Est. Completion 2022-10-15
Phase NA
Mayo Clinic

2,844 total trials

What the finished NCT05555407 record still lists

NCT05555407 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 23 participants, a relatively small participant target, below the 132-participant average among 5 other Gastric Emptying trials with a reported enrollment target (83% lower).

The record links to 1 condition, with Gastric Emptying appearing as the primary indexed condition, and to 2 interventions - of which Scintigraphic gastric emptying scan is the first listed.

NCT05555407 reports a single indexed study location in Florida.

Frequently Asked Questions

What is clinical trial NCT05555407 about?

NCT05555407 is a clinical study titled "Feasibility of a Wireless Patch System (WPS) to Measure Gastrointestinal Motility and Gastric Emptying". The purpose of this study is to evaluate the utility of a new device - an external wireless patch system (WPS) - to measure gastric motility and to compare this external wearable device with the most commonly used test to measure stomach emptying, the nuclear medicine gastric emptying scan (also cal...

What is the current status of trial NCT05555407?

This trial is currently completed. It is a NA study. The enrollment target is 23 participants. The study started on 2022-08-01. Estimated completion is 2022-10-15.

What conditions does trial NCT05555407 study?

This clinical trial studies the following conditions: Gastric Emptying.

What interventions are being tested in trial NCT05555407?

The interventions under investigation include: Scintigraphic gastric emptying scan (DIAGNOSTIC_TEST), Wireless patch system (WPS) (DEVICE).

Who is sponsoring clinical trial NCT05555407?

This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05555407 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Gastric Emptying

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03616041 · 23 participants

    Capsule Endoscopy for Severe Hematochezia

  • NCT04348747 · 23 participants · Phase 2

    Dendritic Cell Vaccines Against Her2/Her3 and Pembrolizumab for the Treatment of Brain Metastasis From Triple Negative Breast Cancer or HER2+ Breast Cancer

  • NCT04587687 · 23 participants · Phase 2

    Brentuximab Vedotin and Bendamustine for the Treatment of Relapsed or Refractory Follicular Lymphoma

  • NCT04715022 · 23 participants · Phase 1

    Sympathetic-vascular Dysfunction in Obesity and Insulin Resistance (Vitamin C Study)

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05555407, the US trial registry maintained by the National Library of Medicine. NCT05555407 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.